Seeking Alpha

Novartis (NVS) plans to file for Japanese and EU approval of QVA149 - a therapy that combines...

Novartis (NVS) plans to file for Japanese and EU approval of QVA149 - a therapy that combines two of the company's other drugs and is used to treat smoker's cough - later this year after it met expectations in final trials. Yesterday, the FDA authorized a new dosage of Novartis' cancer drug Afinitor so it can be used to treat children with a rare brain tumor. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs